Marc Wiesenberger
Stock Analyst at B. Riley Securities
(3.02)
# 1,177
Out of 4,818 analysts
32
Total ratings
62.96%
Success rate
52.03%
Average return
Main Sectors:
Stocks Rated by Marc Wiesenberger
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SMLR Semler Scientific | Downgrades: Neutral | $60 → $45 | $34.28 | +31.27% | 7 | Nov 2, 2022 | |
OPRX OptimizeRx | Maintains: Buy | $71 → $56 | $8.45 | +562.72% | 1 | Jul 20, 2022 | |
CLPT ClearPoint Neuro | Reinstates: Buy | $15 | $13.25 | +13.21% | 2 | Apr 5, 2022 | |
OESX Orion Energy Systems | Downgrades: Neutral | $8.5 → $5 | $0.72 | +593.29% | 5 | Nov 10, 2021 | |
ZYXI Zynex | Upgrades: Buy | $18 | $2.44 | +626.64% | 9 | Jul 16, 2021 | |
NSIT Insight Enterprises | Maintains: Buy | $67 → $64 | $133.29 | -52.36% | 3 | May 11, 2020 | |
LPTH LightPath Technologies | Maintains: Buy | $2.1 → $3.25 | $2.00 | +62.50% | 5 | May 8, 2020 |
Semler Scientific
Nov 2, 2022
Downgrades: Neutral
Price Target: $60 → $45
Current: $34.28
Upside: +31.27%
OptimizeRx
Jul 20, 2022
Maintains: Buy
Price Target: $71 → $56
Current: $8.45
Upside: +562.72%
ClearPoint Neuro
Apr 5, 2022
Reinstates: Buy
Price Target: $15
Current: $13.25
Upside: +13.21%
Orion Energy Systems
Nov 10, 2021
Downgrades: Neutral
Price Target: $8.5 → $5
Current: $0.72
Upside: +593.29%
Zynex
Jul 16, 2021
Upgrades: Buy
Price Target: $18
Current: $2.44
Upside: +626.64%
Insight Enterprises
May 11, 2020
Maintains: Buy
Price Target: $67 → $64
Current: $133.29
Upside: -52.36%
LightPath Technologies
May 8, 2020
Maintains: Buy
Price Target: $2.1 → $3.25
Current: $2.00
Upside: +62.50%